Joshua M. Nelson is an independent director of the company. He is an independent director who joined our Board in August 2017 and serves on the Compensation and Management Development Committee. Since 2003, Mr. Nelson has been an investment professional at THL, where he is currently a Managing Director and Head of Healthcare. Prior to joining THL, he worked at JPMorgan Partners, the private equity affiliate of JPMorgan Chase. Mr. Nelson currently serves on the board of Agiliti Health, Inc. (Compensation Committee and Nominating and Corporate Governance Committee member), Centria Healthcare (Compensation Committee member), CSafe Global (Compensation Committee member), Healthcare Staffing Services, Inc. (Compensation Committee member) and Professional Physical Therapy Inc. (Compensation Committee member). He previously served on the board of 1-800 CONTACTS, Inc. (Compensation Committee member), Advanced BioEnergy, LLC (Compensation Committee member), Curo Health Services, Inc. (Audit Committee, Compensation Committee and Compliance Committee member), Intermedix Corporation (Audit Committee and Compensation Committee member), Party City Holdings, Inc. (NYSE:PRTY) (Compensation Committee and Nominating Committee member) and Hawkeye Energy Holdings. Mr. Nelson received his Bachelor of Arts in political science, summa cum laude, from Princeton University and his MBA, with honors, from Harvard Business School.
As the Independent Director of Syneos Health Inc, the total compensation of Joshua Nelson at Syneos Health Inc is $257,750. There are 15 executives at Syneos Health Inc getting paid more, with Alistair Macdonald having the highest compensation of $7,646,360.
Joshua Nelson is 47, he's been the Independent Director of Syneos Health Inc since 2017. There are 15 older and 6 younger executives at Syneos Health Inc. The oldest executive at Syneos Health Inc is William Klitgaard, 67, who is the Independent Director.
Joshua's mailing address filed with the SEC is C/O THOMAS H. LEE PARTNERS, L.P., 100 FEDERAL STREET, 35TH FLOOR, BOSTON, MA, 02110.
Over the last 7 years, insiders at Syneos Health Inc have traded over $16,280,601,287 worth of Syneos Health Inc stock and bought 17,946 units worth $873,496 . The most active insiders traders include Todd M Abbrecht, John L. Maldonado a Tom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of $83,067,962. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth $117,156.
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
Syneos Health Inc executives and other stock owners filed with the SEC include: